Isis, Xenon in antisense deal

Xenon Pharmaceuticals Inc. (Burnaby, B.C.) partnered with Isis Pharmaceuticals Inc. (NASDAQ:ISIS) to discover and develop antisense therapeutics to treat anemia of inflammation. Isis will discover can...